Arnold L Oronsky's Net Worth

$452 Million

Who is Arnold L Oronsky?

Arnold L Oronsky has an estimated net worth of $452 Million. This is based on reported shares across multiple companies, which include EnteroMedics Inc, INTRALASE CORP, Invuity, Inc., Trius Therapeutics Inc, GLAUKOS Corp, Eiger BioPharmaceuticals, Inc., KalVista Pharmaceuticals, Inc., Marketo, Inc., OBALON THERAPEUTICS INC, Venus Concept Inc., Transcept Pharmaceuticals Inc, EPOCRATES INC, METABASIS THERAPEUTICS INC, AVEDRO INC, DYNAVAX TECHNOLOGIES CORP, ANESIVA, INC., PMV Pharmaceuticals, Inc., MACROGENICS INC, TESARO, Inc., APPLIED GENETIC TECHNOLOGIES CORP, MYOGEN INC, and CORIXA CORP.

SEC CIK

Arnold L Oronsky's CIK is 0001207833

Past Insider Trading and Trends

2014 was Arnold L Oronsky's most active year for acquiring shares with 39 total transactions. Arnold L Oronsky's most active month to acquire stocks was the month of May. 2005 was Arnold L Oronsky's most active year for disposing of shares, totalling 45 transactions. Arnold L Oronsky's most active month to dispose stocks was the month of October. 2007 saw Arnold L Oronsky paying a total of $9,500,001.45 for 3,552,070 shares, this is the most they've acquired in one year. In 2013 Arnold L Oronsky cashed out on 40,770,500 shares for a total of $70,818,664.12, their largest year based on trade value.